Immunology and Microbiology Devices; Classification of Norovirus Serological Reagents

Document ID: FDA-2012-N-0165-0001
Document Type: Rule
Agency: Food And Drug Administration
Topics: Biologics, Laboratories, Medical Devices
Federal Register Number: 2012-05675
CFR Citation: 21 CFR Part 866
View Document:  View as format pdf View as format html

Details Information

Document Subtype: Final Rule
Received Date: March 09 2012, at 12:00 AM Eastern Standard Time
Start-End Page: 14272 - 14274
Page Count: 3

Attachments:

Petition from R-Biopharm AG, c/o Lehnus and Assocites, dated February 15, 2011

View Attachment: View as format pdf

Petition Attachment 1 - NSE Letter

View Attachment: View as format pdf

Petition Attachment 3 - Lehnus & Associates Consulting

View Attachment: View as format pdf

Pettition Attachment 2 - RIDASCREEN Norovirus 3rd Generation

View Attachment: View as format pdf

Comments

Total: 0
No comments posted.

Related Documents

    More
Total: 12
Microbiology Devices; Reclassification of Nucleic Acid-Based Systems for Mycobacterium tuberculosis Complex in Respiratory Specimens
Immunology and Microbiology Devices: Classification of Norovirus Serological Reagents; Correction
Microbiology Devices: Reclassification of Nucleic Acid-Based Systems for Mycobacterium tuberculosis Complex
Medical Devices: Ovarian Adnexal Mass Assessment Score Test System; Labeling; Black Box Restrictions
Microbiology Devices: Classification of In Vitro Diagnostic Device for Yersinia Species Detection